Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

China Pharma Holdings (CPHI) Short-term Investments (2019)

China Pharma Holdings filings provide 1 years of Short-term Investments readings, the most recent being $109908.0 for Q4 2019.

On a quarterly basis, Short-term Investments changed N/A to $109908.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $109908.0, a N/A change, with the full-year FY2019 number at $109908.0, changed N/A from a year prior.
Short-term Investments hit $109908.0 in Q4 2019 for China Pharma Holdings.
In the past five years, Short-term Investments ranged from a high of $109908.0 in Q4 2019 to a low of $109908.0 in Q4 2019.